quinoxalines has been researched along with pyrazolanthrone in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, SZ; Guo, J; He, W; Kong, FJ; Li, GW; Li, HX; Li, HZ; Tian, Y; Wang, R; Wu, LY; Xi, YH; Xing, WJ; Xu, CQ; Yang, GD | 1 |
| Jin, X; Sun, Y; Tang, SS; Wang, CC; Xiao, XL; Zhang, CM; Zhang, T; Zhao, WX | 1 |
| Tang, S; Wang, C; Xiao, X; Zhang, C; Zhang, S; Zhao, D; Zhou, Y | 1 |
| Kato, H; Morishita, S; Murakoshi, M; Nishino, H; Ono, T; Saito, K; Sugiyama, K; Tomita, K | 1 |
| Dai, C; Li, B; Li, D; Tang, S; Xiao, X; Yang, X | 1 |
| Anfinogenova, YD; Atochin, DN; Schepetkin, IA; Shvedova, MV | 1 |
1 review(s) available for quinoxalines and pyrazolanthrone
| Article | Year |
|---|---|
[JUN N-TERMINAL KINASES AND THEIR PHARMACOLOGICAL MODULATION OF ISCHE-MIC AND REPERFUSION INJURY OF THE BRAIN].
Topics: Acetonitriles; Animals; Anthracenes; Benzothiazoles; Brain; Brain Ischemia; Gene Expression Regulation; Ginsenosides; Humans; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinase 10; Neuroprotective Agents; Oximes; Plant Extracts; Protein Kinase Inhibitors; Quinoxalines; Reperfusion Injury; Signal Transduction | 2017 |
5 other study(ies) available for quinoxalines and pyrazolanthrone
| Article | Year |
|---|---|
Involvement of calcium-sensing receptor in oxLDL-induced MMP-2 production in vascular smooth muscle cells via PI3K/Akt pathway.
Topics: Adamantane; Animals; Anthracenes; Aorta; Atherosclerosis; Cells, Cultured; Chromones; Gadolinium; JNK Mitogen-Activated Protein Kinases; Lipoproteins, LDL; Male; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Morpholines; Muscle, Smooth, Vascular; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Calcium-Sensing | 2012 |
Olaquindox-induced apoptosis is suppressed through p38 MAPK and ROS-mediated JNK pathways in HepG2 cells.
Topics: Anthracenes; Apoptosis; Catalase; Cell Line, Tumor; Enzyme Inhibitors; Hep G2 Cells; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Quinoxalines; Reactive Oxygen Species; Superoxide Dismutase | 2013 |
Reactive oxygen species-dependent JNK downregulated olaquindox-induced autophagy in HepG2 cells.
Topics: Adenine; Anthracenes; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Cadaverine; Down-Regulation; Hep G2 Cells; Humans; JNK Mitogen-Activated Protein Kinases; Membrane Proteins; Quinoxalines; Reactive Oxygen Species | 2015 |
Lactoferrin attenuates fatty acid-induced lipotoxicity via Akt signaling in hepatocarcinoma cells.
Topics: Animals; Anthracenes; Apoptosis; Benzimidazoles; Cattle; Fatty Acids, Nonesterified; Hep G2 Cells; Humans; JNK Mitogen-Activated Protein Kinases; Lactoferrin; Lipid Metabolism; Lipotropic Agents; Liver; MAP Kinase Signaling System; Non-alcoholic Fatty Liver Disease; Peptide Fragments; Phosphorylation; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Quinoxalines | 2015 |
GADD45a Regulates Olaquindox-Induced DNA Damage and S-Phase Arrest in Human Hepatoma G2 Cells via JNK/p38 Pathways.
Topics: Animal Feed; Anthracenes; Anti-Bacterial Agents; Apoptosis; Cell Cycle Proteins; Cell Proliferation; Cell Survival; Comet Assay; DNA Fragmentation; Food Additives; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Imidazoles; MAP Kinase Kinase 4; Nuclear Proteins; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Quinoxalines; Reactive Oxygen Species; S Phase; Signal Transduction | 2017 |